Stock Information
Immunovant Inc (IMVT)
Ticker Symbol: IMVT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,093.54 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.8103
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -69.59%
Latest News
-
Immunovant, Inc. (IMVT) Q1 2027 Earnings Call Transcript
Thu, Aug 6, 2026 3:14 PM
-
Immunovant Q1 EPS $(0.75) Misses $(0.61) Estimate
Thu, Aug 6, 2026 7:01 AM
Key Financials
Financial data not available